Clinical Trials
9 trialsNCT04830202 2026-05-13
Expanded Access to Telisotuzumab Vedotin
AbbVie
Temporarily not available
NCT07346105 2026-01-16
Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies
Orca Biosystems, Inc.
Temporarily not available
NCT07319910 2026-01-06
PANOVA-3CA
NovoCure Ltd.
Temporarily not available
NCT05389514 2025-11-20
Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors
Providence Health & Services
Temporarily not available
NCT03842865 2025-06-05
Expanded Access of Vigil in Solid Tumors
Gradalis, Inc.
Temporarily not available
NCT06033001 2025-01-13
Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Lantheus Medical Imaging
Temporarily not available
NCT05274204 2023-02-27
Individual Patient Expanded Access to CA102N
Holy Stone Healthcare Co., Ltd
Temporarily not available
NCT02011880 2013-12-13
Standardization Research of TCM Syndrome Differentiation and Treatment on Advanced Breast Cancer
Shanghai University of Traditional Chinese Medicine
Temporarily not available
NCT01297101 2011-02-16
Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy
Shanghai Chest Hospital
Temporarily not available